IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer. - Cortés-Sempere, M; de Miguel, M P; Pernía, O; Rodriguez, C; de Castro Carpeño, J; Nistal, M; Conde, E; López-Ríos, F; Belda-Iniesta, C; Perona, R; de Caceres, I Ibanez (Oncogene, 2013)